Mesalazine Therapy in Patients With Irritable Bowel Syndrome

NCT00626288 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

187

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: Mesalazine
DRUG: Placebo

Sponsor

SOFAR S.p.A.